Beroni Logo @ Dec 2019.png
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
October 19, 2020 08:53 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise,...
Beroni Logo @ Dec 2019.png
Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19
August 12, 2020 09:30 ET | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), is pleased to announce that further to its announcement on August...